Heart 2008;94:585-589
HEART FAILURE AND CARDIOMYOPATHY
Clinical and prognostic implications of self-rating depression scales and plasma B-type natriuretic peptide in hospitalised patients with chronic heart failure
Heart Failure Clinic, Second Department of Cardiology, Attikon University Hospital, Athens, Greece
John T Parissis, MD, FESC, Aftokratoros Irakliou 17, 15122 Maroussi, Athens, Greece; jparissis{at}yahoo.com
Background: Depression is common among patients with chronic heart failure (CHF) and has been independently associated with a poorer prognosis.
Purpose: This study evaluated the clinical and prognostic value of depression scales (Beck Depression Inventory (BDI), Zung Self-rating Depression Scale (Zung SDS)) along with plasma B-type natriuretic peptide (BNP) in CHF.
Methods: 155 hospitalised CHF patients (ejection fraction 26.9% (SD 6.4%)) were studied by depression (BDI, Zung SDS) and functional questionnaires (Kansas City Cardiomyopathy Questionnaire (KCCQ), Duke Activity Status Index (DASI)), BNP and 6-minute walk test (6MWT). Patients were followed for 6 months for cardiovascular events, including death from any cause or rehospitalisation for CHF decompensation.
Results: Seventy-six (49%) patients with depressive symptoms, as estimated by both scales, had significantly lower DASI and KCCQ scores (13.2 (SD 9.9) vs 23.6 (SD 13.0) and 26.6 (SD 15.0) vs 45.0 (SD 17.0), respectively; p<0.001), higher BNP (921 (SD 889) vs 439 (SD 267) pg/ml, p = 0.001) and reduced 6MWT (270 (SD 130) vs 337 (SD 133); p<0.001). According to logistic regression analysis, Zung SDS and BNP were independently associated with adverse clinical outcomes; values of Zung SDS
40 and of BNP
290 pg/ml predicted future events with a sensitivity of 82% and 94% and a specificity of 45% and 46%, respectively. The combination of Zung SDS plus BNP had an additive prognostic value, predicting events with a sensitivity of 77% and a specificity of 70% (event-free survival: Zung <40 and BNP <290 pg/ml; 170 (SD 9) days; Zung
40 and BNP <290 pg/ml, 159 (SD 14) days; Zung <40 and BNP
290 pg/ml, 118 (SD 15) days; Zung
40 and BNP
290 pg/ml, 73 (SD 8) days, p<0.001).
Conclusions: CHF patients with depressive symptoms have impaired physical activity, associated with excessive neurohormonal activation. Among the studied scales, Zung SDS seemed to independently predict clinical outcome, especially in patients with increased plasma BNP concentration. Hence, the combination of those two modalities provides a practical means for risk stratification in CHF.
Relevant Article
- Natriuretic peptides or psychometric tests? Prognostic markers in congestive heart failure
- Christoph Herrmann-Lingen and Burkert Pieske
Heart 2008 94: 545-546.[Extract] [Full Text] [PDF]
This article has been cited by other articles:
-
Parissis, J. T., Farmakis, D., Nikolaou, M., Birmpa, D., Bistola, V., Paraskevaidis, I., Ikonomidis, I., Gaitani, S., Venetsanou, K., Filippatos, G., Kremastinos, D. Th.
(2009). Plasma B-type natriuretic peptide and anti-inflammatory cytokine interleukin-10 levels predict adverse clinical outcome in chronic heart failure patients with depressive symptoms: a 1-year follow-up study. Eur J Heart Fail
11: 967-972
[Abstract] [Full Text] -
Parissis, J. T., Nikolaou, M., Farmakis, D., Paraskevaidis, I. A., Bistola, V., Venetsanou, K., Katsaras, D., Filippatos, G., Kremastinos, D. T.
(2009). Self-assessment of health status is associated with inflammatory activation and predicts long-term outcomes in chronic heart failure. Eur J Heart Fail
11: 163-169
[Abstract] [Full Text] -
Pedersen, S. S., Kupper, N., Denollet, J.
(2009). CHAPTER 35 Psychological Factors and Heart Disease. ESC Textbook of Cardiovascular Medicine
2: med-9780199566990-chapter-med-9780199566990-chapter
[Abstract] [Full Text] -
Karavidas, A., Parissis, J., Arapi, S., Farmakis, D., Korres, D., Nikolaou, M., Fotiadis, J., Potamitis, N., Driva, X., Paraskevaidis, I., Matsakas, E., Filippatos, G., Kremastinos, D. T.
(2008). Effects of functional electrical stimulation on quality of life and emotional stress in patients with chronic heart failure secondary to ischaemic or idiopathic dilated cardiomyopathy: A randomised, placebo-controlled trial. Eur J Heart Fail
10: 709-713
[Abstract] [Full Text] -
Herrmann-Lingen, C., Pieske, B.
(2008). Natriuretic peptides or psychometric tests? Prognostic markers in congestive heart failure. Heart
94: 545-546
[Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
